International Journal of Neonatal Screening Events Announce Your Event Here

No upcoming events

14–17 October 2018 11th ISNS European Regional Meeting

Bratislava, Slovakia

On behalf of the Local Organising Committee and the ISNS Council it is my pleasure to welcome you to the 11th ISNS European Regional Meeting taking place this year in Bratislava, Slovakia, October 14-17, 2018.
Scientific and technological advancements are rapidly enabling neonatal screening for ever more congenital conditions to become available. We very much look forward to hearing about some of these in this conference. The potential to significantly expand the scope of newborn screening reminds us that it is also worthwhile taking a step back and reviewing experience acquired by earlier newborn screening programmes. The keyword here is reliability. Reliability applies to all aspects of the screening process - analytical reliability (is our methodology in order?), clinical reliability (do we identify affected infants efficiently?), cost-effectiveness reliability (do we get value for money?) and more.
As the conference programme is gradually developed screening for new conditions will be highlighted with an important emphasis on reliability.

15–16 June 2018 25th Annual Meeting of German Society of Newborn Screening

Vienna, Austria

Dear Guests,
dear Colleagues,

we are pleased to invite you to the 25 th Annual Meeting of the German Society for Newborn Screening (DGNS). Noteworthy, this meeting for the first time will take place outside of Germany – in Vienna. Thus we hope that beyond an interesting scientific program we can offer a nice cultural ambience. Moreover, we would like to take advantage of the location Vienna to foster contact and exchange to our neighboring countries.
Following the theme “review-insights-outlook”, the program will highlight achievements, focus on the present problem of recalls and false-positive results, and view into the future with the emphasis on SCID and other not yet screened conditions.
We hope you will join us and take part in the scientific program by submitting abstracts on these or related topics.
We are looking forward to meeting you and a fruitful exchange of opinions and experience.

Vassiliki Konstantopoulou
Maximilian Zeyda

22–24 May 2018 6th International Molecular Diagnostics Europe

Lisbon, Portugal

Cambridge Healthtech Institute’s Sixth International Molecular Diagnostics Europe event will return to Lisbon on 22-24 May 2018. This meeting provides a nexus for diagnostic developers in academia and industry as well as end-users in the pharmaceutical and healthcare sector to gain a comprehensive picture of molecular diagnostics in prenatal, oncology, infectious disease, point-of-care, and liquid biopsy. This exciting area has attracted attendance of over 400 delegates to learn what novel technologies, platforms and applications are emerging that will impact future healthcare delivery and pharmaceutical research. Join us this spring at this expanding event at the epicenter of diagnostics.

9–12 May 2018 52th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

Athens Greece

The AEPC Annual Meeting has a long tradition of bringing together not only Pediatric Cardiologists, but also specialists from all the disciplines dedicated to the care of patients with congenital heart disease, from fetal life to adulthood, with delegates coming both from Europe and from around the world, in ever increasing numbers. The Scientific Program is founded on the multidisciplinary approach to the field of Pediatric and Congenital Heart Disease, focusing on latest developments, innovations, and future trends. At the same time, great emphasis will remain on basic and advanced educational opportunities, targeting not only accomplished specialists, but also more junior staff, trainees, nurses and students. There will be expert invited lectures and exciting sessions of
the AEPC Working Groups, with broad and in - depth coverage of the varied topics of interest in our field. Highlights will include the Update Course on Transposition of the Great Arteries, and several sessions co-organized by multiple AEPC Working Groups, which will provide all-around coverage of important issues including morphology, imaging, as well as catheter and surgical interventions.

30 November–1 December 2017 3rd Annual Reproductive Genetic Diagnostics

Hyatt Regency Cambridge, Cambridge, MA

Couples undergoing infertility treatments are more aware than ever of preimplantation genetic screening and diagnosis, yet patients and practitioners alike are still struggling with understanding the technologies being used, their capabilities and limitations, and their clinical, legal, and ethical implications. Cambridge Healthtech Institute’s Third Annual Reproductive Genetic Diagnostics conference aims to highlight a number of technologies and their differences, as well as how effective they are at uncovering a variety of genetic abnormalities. Considerations for mosaic embryos, biopsy techniques, and genetic counseling will also be discussed. Special attention will be paid to expanded carrier screening, its role in the direct-to-consumer market, and the potential for other molecular tests for infertility and implantation failure. Future directions for the role of gene editing and non-invasive embryo diagnostics will also be discussed.

28–29 November 2017 5th Annual Advances in Prenatal Molecular Diagnostics

Hyatt Regency Cambridge, Cambridge, MA

Cell-free DNA-based screening and the potential for cell-based screening has upended the field of prenatal testing. While cell-free tests are being used more and more in the clinic, cell-based tests are still on the cusp of commercialization. With both types of tests still in need of improvements in order to truly replace invasive tests, the near-term challenge is determining where the field heads once both options are viable. This meeting will discuss updated comparisons and examine the implementation, insurance, and clinical challenges associated with each test.

Furthermore, with advances in DNA amplification and sequencing comes greater opportunity to garner more information. Much discussion needs to take place in regards to the role of preconception counseling, expanded carrier screening, whole genome versus whole exome sequencing, and the effect these and any prenatal testing may have on the decision to continue a pregnancy or perform fetal therapy.

10–13 September 2017 2017 Newborn Screening and Genetic Testing Symposium

New Orleans, Louisiana, USA

The meeting will address state, national and international newborn screening, genetic testing and policy issues important to national and global public health. This conference is sponsored by: The Association of Public Health Laboratories, and co-sponsored by The Louisiana State Public Health Laboratory and International Society for Neonatal Screening.

5–8 September 2017 13th International Congress of Inborn Errors of Metabolism

Rio De Janeiro, Brazil

Rio will be ready to receive the ICIEM 2017 participants with its very well connected international airport, impressive infrastructure and diversity of tourist options. The meeting will take place in a brand new convention center located at Barra da Tijuca beach, a modern and vibrant district not far from the airport and from the world famous Copacabana and Ipanema beaches.

29 November–1 December 2016 Fourth Annual Advances in Prenatal Molecular Diagnostics

Boston Marriott Cambridge, Cambridge, MA, USA

Research into testing based on isolation of fetal cells from maternal blood has been underway for decades, and the discussion has been couched in terms of “if this approach can be commercialized”. At this meeting last year, for the first time, the conversation shifted to “when this approach is commercialized” as numerous groups reported substantial progress in achieving reliable isolation that would make this possible. Updated comparisons and examination of these issues, and the implementation of these different approaches, will again make for lively discussion and insight into where this field is headed and ways for researchers, test providers, clinicians and clinics to take these developments into consideration.

11–14 September 2016 9th ISNS International Meeting & 10th ISNS European Regional Meeting

The Hague, The Netherlands

The conference will aid the sharing of neonatal screening experiences for congenital metabolic disorders, its clinical diagnostics and follow-up, and will facilitate learning from other experiences. The programme will consist of plenary lectures, oral presentations and poster sessions and will be attractive for professionals, patient/advocacy groups, policy makers and industrial partners. The programme will include evaluation of performance of neonatal screening systems and strategies for improvement.

3–4 June 2016 23rd Annual Meeting of the German Society for Neonatal Screening (DGNS)

Heidelberg, Germany

The main topic of the conference will be, “New Target Disorders in Newborn Screening”. There will be talks about Cystic Fibrosis, pilot screening programs for tyrosinaemia typ-I, methylmalonic acidaemia, propionic acidaemia, creatin synthesis disorders, and disorders of remethylation.

Int. J. Neonatal Screen. EISSN 2409-515X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top